Dual Antifibrotic Modulation via CTGF Silencing and Peptide Amphiphile Nanofibers for Topical Treatment of Skin Fibrosis

Ayça Eroğlu, Gulcihan Gulseren, Deniz Sezlev Bilecen

Open source

DOI
10.1021/acs.molpharmaceut.6c00479
Published
2026-09-25
Container
Molecular Pharmaceutics
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.6c00479,
  title = {Dual Antifibrotic Modulation via CTGF Silencing and Peptide Amphiphile Nanofibers for Topical Treatment of Skin Fibrosis},
  author = {Ayça Eroğlu and Gulcihan Gulseren and Deniz Sezlev Bilecen},
  year = {2026},
  journal = {Molecular Pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.6c00479},
  url = {https://doi.org/10.1021/acs.molpharmaceut.6c00479}
}

RIS

TY  - JOUR
TI  - Dual Antifibrotic Modulation via CTGF Silencing and Peptide Amphiphile Nanofibers for Topical Treatment of Skin Fibrosis
AU  - Ayça Eroğlu
AU  - Gulcihan Gulseren
AU  - Deniz Sezlev Bilecen
PY  - 2026
JO  - Molecular Pharmaceutics
DO  - 10.1021/acs.molpharmaceut.6c00479
UR  - https://doi.org/10.1021/acs.molpharmaceut.6c00479
ER  - 

APA

Eroğlu, A., Gulseren, G., & Bilecen, D. S. (2026). Dual Antifibrotic Modulation via CTGF Silencing and Peptide Amphiphile Nanofibers for Topical Treatment of Skin Fibrosis. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00479

Source records